trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastické činidlá - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
vyepti
h. lundbeck a/s - eptinezumab - poruchy migrény - analgetiká - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
xiltess 20 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
xiltess 15 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
rivaroxaban stada 15 mg tvrdé kapsuly
stada arzneimittel ag, nemecko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
rivaroxaban stada 20 mg tvrdé kapsuly
stada arzneimittel ag, nemecko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
enkia 20 mg filmom obalené tablety
medochemie ltd., cyprus - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
enkia 15 mg filmom obalené tablety
medochemie ltd., cyprus - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
bevimlar 15 mg filmom obalené tablety
stada arzneimittel ag, nemecko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)